Skip to main content
Top
Published in: Tumor Biology 9/2014

01-09-2014 | Research Article

RETRACTED ARTICLE: Relationships between genetic polymorphisms in inflammation-related factor gene and the pathogenesis of nasopharyngeal cancer

Authors: Yan-Li Qu, Hong Yu, Yan-Zhi Chen, Yu-Xia Zhao, Guang-Jun Chen, Lu Bai, Dan Liu, Hong-Xin Su, He-Tong Wang

Published in: Tumor Biology | Issue 9/2014

Login to get access

Abstract

Our study aims to discuss the association between inflammation-related factors such as single nucleotide polymorphisms (SNPs) with susceptibility and recurrence in nasopharyngeal carcinoma. We used Taqman real-time polymerase chain reaction (PCR) to characterize the genetic variation of five SNPs in 194 nasopharyngeal carcinoma patients and 231 healthy subjects. All statistical analysis is performed with statistical product and service solutions v13.0; odds ratio (OR) value and 95 % confidence interval (CI) were calculated. There is no relationship between TGFβ1 –869 T/C, IL-6 –634C/G, TGFβ1 –509C/T, IL1 –511C/T and nasopharyngeal carcinoma susceptibility. Both single factor and multiple factors analysis showed that IL1a –889 T/T genotype is significantly associated with nasopharyngeal carcinoma in decreasing the risk of nasopharyngeal carcinoma. A highly significant association was found between IL1a –889 T/T genotype and protective genotype as defined by various pathological types. This is more obvious in the protective genotype of the non-keratin-type squamous carcinoma undifferentiated type. We also discovered that genotype G/G and C/G + G/G of IL6 –634 gene are associated with reduced recurrence of nasopharyngeal carcinoma. IL1a –889 gene polymorphism and susceptibility is related to nasopharyngeal carcinoma and can potentially decrease the risk of nasopharyngeal carcinoma in the Han Chinese population in north China. IL1-889 TT genotype is protective genotype for nasopharyngeal carcinoma. We have provided evidence that the GG genotype of the IL6 –634 gene is associated with recurrent risk of nasopharyngeal carcinoma. The G allele is the protective gene of nasopharyngeal carcinoma recurrence.
Literature
1.
go back to reference Shi W, Alajez NM, Bastianutto C, Hui AB, Mocanu JD, Ito E, et al. Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer. Int J Cancer. 2010;126(9):2036–48.PubMed Shi W, Alajez NM, Bastianutto C, Hui AB, Mocanu JD, Ito E, et al. Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer. Int J Cancer. 2010;126(9):2036–48.PubMed
2.
go back to reference Luo W, Fang W, Li S, Yao K. Aberrant expression of nuclear vimentin and related epithelial–mesenchymal transition markers in nasopharyngeal carcinoma. Int J Cancer. 2012;131(8):1863–73.CrossRefPubMed Luo W, Fang W, Li S, Yao K. Aberrant expression of nuclear vimentin and related epithelial–mesenchymal transition markers in nasopharyngeal carcinoma. Int J Cancer. 2012;131(8):1863–73.CrossRefPubMed
3.
go back to reference Lee N, Harris J, Garden AS, Straube W, Glisson B, Xia P, et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol. 2009;27(22):3684–90.PubMedCentralCrossRefPubMed Lee N, Harris J, Garden AS, Straube W, Glisson B, Xia P, et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol. 2009;27(22):3684–90.PubMedCentralCrossRefPubMed
4.
go back to reference Ma N, Kawanishi M, Hiraku Y, Murata M, Huang GW, Huang Y, et al. Reactive nitrogen species-dependent DNA damage in EBV-associated nasopharyngeal carcinoma: the relation to STAT3 activation and EGFR expression. Int J Cancer. 2008;122(11):2517–25.CrossRefPubMed Ma N, Kawanishi M, Hiraku Y, Murata M, Huang GW, Huang Y, et al. Reactive nitrogen species-dependent DNA damage in EBV-associated nasopharyngeal carcinoma: the relation to STAT3 activation and EGFR expression. Int J Cancer. 2008;122(11):2517–25.CrossRefPubMed
5.
go back to reference Wang J, Bai S, Chen N, Xu F, Jiang X, Li Y, et al. The clinical feasibility and effect of online cone beam computer tomography-guided intensity-modulated radiotherapy for nasopharyngeal cancer. Radiother Oncol. 2009;90(2):221–7.CrossRefPubMed Wang J, Bai S, Chen N, Xu F, Jiang X, Li Y, et al. The clinical feasibility and effect of online cone beam computer tomography-guided intensity-modulated radiotherapy for nasopharyngeal cancer. Radiother Oncol. 2009;90(2):221–7.CrossRefPubMed
6.
go back to reference Tham IW, Hee SW, Yeo RM, Salleh PB, Lee J, Tan TW, et al. Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy—the National Cancer Centre Singapore experience. Int J Radiat Oncol Biol Phys. 2009;75(5):1481–6.CrossRefPubMed Tham IW, Hee SW, Yeo RM, Salleh PB, Lee J, Tan TW, et al. Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy—the National Cancer Centre Singapore experience. Int J Radiat Oncol Biol Phys. 2009;75(5):1481–6.CrossRefPubMed
7.
go back to reference Zhang L, Deng T, Li X, Liu H, Zhou H, Ma J, et al. microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network. Carcinogenesis. 2010;31(4):559–66.CrossRefPubMed Zhang L, Deng T, Li X, Liu H, Zhou H, Ma J, et al. microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network. Carcinogenesis. 2010;31(4):559–66.CrossRefPubMed
8.
go back to reference Hsu WL, Chen JY, Chien YC, Liu MY, You SL, Hsu MM, et al. Independent effect of EBV and cigarette smoking on nasopharyngeal carcinoma: a 20-year follow-up study on 9,622 males without family history in Taiwan. Cancer Epidemiol Biomarkers Prev. 2009;18(4):1218–26.CrossRefPubMed Hsu WL, Chen JY, Chien YC, Liu MY, You SL, Hsu MM, et al. Independent effect of EBV and cigarette smoking on nasopharyngeal carcinoma: a 20-year follow-up study on 9,622 males without family history in Taiwan. Cancer Epidemiol Biomarkers Prev. 2009;18(4):1218–26.CrossRefPubMed
9.
go back to reference Zhu Y, Xu Y, Wei Y, Liang W, Liao M, Zhang L. Association of IL-1B gene polymorphisms with nasopharyngeal carcinoma in a Chinese population. Clin Oncol R Coll Radiol. 2008;20(3):207–11.CrossRefPubMed Zhu Y, Xu Y, Wei Y, Liang W, Liao M, Zhang L. Association of IL-1B gene polymorphisms with nasopharyngeal carcinoma in a Chinese population. Clin Oncol R Coll Radiol. 2008;20(3):207–11.CrossRefPubMed
10.
go back to reference Yang EV, Kim SJ, Donovan EL, Chen M, Gross AC, Webster Marketon JI, et al. Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav Immun. 2009;23(2):267–75.PubMedCentralCrossRefPubMed Yang EV, Kim SJ, Donovan EL, Chen M, Gross AC, Webster Marketon JI, et al. Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav Immun. 2009;23(2):267–75.PubMedCentralCrossRefPubMed
11.
go back to reference Taylor SL, Renshaw BR, Garka KE, Smith DE, Sims JE. Genomic organization of the interleukin-1 locus. Genomics. 2002;79(5):726–33.CrossRefPubMed Taylor SL, Renshaw BR, Garka KE, Smith DE, Sims JE. Genomic organization of the interleukin-1 locus. Genomics. 2002;79(5):726–33.CrossRefPubMed
12.
go back to reference Hsu SM, Waldron Jr JW, Hsu PL, Hough Jr AJ. Cytokines in malignant lymphomas: review and prospective evaluation. Hum Pathol. 1993;24(10):1040–57.CrossRefPubMed Hsu SM, Waldron Jr JW, Hsu PL, Hough Jr AJ. Cytokines in malignant lymphomas: review and prospective evaluation. Hum Pathol. 1993;24(10):1040–57.CrossRefPubMed
13.
go back to reference Matsuo K, Hamajima N, Suzuki R, Nakamura S, Seto M, Morishima Y, et al. No substantial difference in genotype frequencies of interleukin and myeloperoxidase polymorphisms between malignant lymphoma patients and non-cancer controls. Haematologica. 2001;86(6):602–8.PubMed Matsuo K, Hamajima N, Suzuki R, Nakamura S, Seto M, Morishima Y, et al. No substantial difference in genotype frequencies of interleukin and myeloperoxidase polymorphisms between malignant lymphoma patients and non-cancer controls. Haematologica. 2001;86(6):602–8.PubMed
14.
go back to reference Landeck L, Visser M, Kezic S, John SM. IL1A-889 C/T gene polymorphism in irritant contact dermatitis. J Eur Acad Dermatol Venereol. 2013;27(8):1040–3.CrossRefPubMed Landeck L, Visser M, Kezic S, John SM. IL1A-889 C/T gene polymorphism in irritant contact dermatitis. J Eur Acad Dermatol Venereol. 2013;27(8):1040–3.CrossRefPubMed
15.
go back to reference Snoussi K, Strosberg AD, Bouaouina N, Ben Ahmed S, Chouchane L. Genetic variation in pro-inflammatory cytokines (interleukin-1beta, interleukin-1alpha and interleukin-6) associated with the aggressive forms, survival, and relapse prediction of breast carcinoma. Eur Cytokine Netw. 2005;16(4):253–60.PubMed Snoussi K, Strosberg AD, Bouaouina N, Ben Ahmed S, Chouchane L. Genetic variation in pro-inflammatory cytokines (interleukin-1beta, interleukin-1alpha and interleukin-6) associated with the aggressive forms, survival, and relapse prediction of breast carcinoma. Eur Cytokine Netw. 2005;16(4):253–60.PubMed
16.
go back to reference Shirodaria S, Smith J, McKay IJ, Kennett CN, Hughes FJ. Polymorphisms in the IL-1A gene are correlated with levels of interleukin-1alpha protein in gingival crevicular fluid of teeth with severe periodontal disease. J Dent Res. 2000;79(11):1864–9.CrossRefPubMed Shirodaria S, Smith J, McKay IJ, Kennett CN, Hughes FJ. Polymorphisms in the IL-1A gene are correlated with levels of interleukin-1alpha protein in gingival crevicular fluid of teeth with severe periodontal disease. J Dent Res. 2000;79(11):1864–9.CrossRefPubMed
17.
go back to reference Singer CF, Hudelist G, Gschwantler-Kaulich D, Fink-Retter A, Mueller R, Walter I, et al. Interleukin-1alpha protein secretion in breast cancer is associated with poor differentiation and estrogen receptor alpha negativity. Int J Gynecol Cancer. 2006;16 Suppl 2:556–9.CrossRefPubMed Singer CF, Hudelist G, Gschwantler-Kaulich D, Fink-Retter A, Mueller R, Walter I, et al. Interleukin-1alpha protein secretion in breast cancer is associated with poor differentiation and estrogen receptor alpha negativity. Int J Gynecol Cancer. 2006;16 Suppl 2:556–9.CrossRefPubMed
18.
go back to reference Singer CF, Kronsteiner N, Hudelist G, Marton E, Walter I, Kubista M, et al. Interleukin 1 system and sex steroid receptor expression in human breast cancer: interleukin 1alpha protein secretion is correlated with malignant phenotype. Clin Cancer Res. 2003;9(13):4877–83.PubMed Singer CF, Kronsteiner N, Hudelist G, Marton E, Walter I, Kubista M, et al. Interleukin 1 system and sex steroid receptor expression in human breast cancer: interleukin 1alpha protein secretion is correlated with malignant phenotype. Clin Cancer Res. 2003;9(13):4877–83.PubMed
19.
go back to reference Eshghyar N, Nikbin B, Amirzargar A, Dehghani Nazhvani A, Shakiba Y. Gene polymorphism of interleukin-1 alpha and beta in keratocystic odontogenic tumors. J Oral Pathol Med. 2012;41(9):697–701.CrossRefPubMed Eshghyar N, Nikbin B, Amirzargar A, Dehghani Nazhvani A, Shakiba Y. Gene polymorphism of interleukin-1 alpha and beta in keratocystic odontogenic tumors. J Oral Pathol Med. 2012;41(9):697–701.CrossRefPubMed
20.
go back to reference Hefler LA, Grimm C, Lantzsch T, Lampe D, Leodolter S, Koelbl H, et al. Interleukin-1 and interleukin-6 gene polymorphisms and the risk of breast cancer in caucasian women. Clin Cancer Res. 2005;11(16):5718–21.CrossRefPubMed Hefler LA, Grimm C, Lantzsch T, Lampe D, Leodolter S, Koelbl H, et al. Interleukin-1 and interleukin-6 gene polymorphisms and the risk of breast cancer in caucasian women. Clin Cancer Res. 2005;11(16):5718–21.CrossRefPubMed
21.
go back to reference Hurme M, Helminen M. Polymorphism of the IL-1 gene complex in Epstein–Barr virus seronegative and seropositive adult blood donors. Scand J Immunol. 1998;48(3):219–22.CrossRefPubMed Hurme M, Helminen M. Polymorphism of the IL-1 gene complex in Epstein–Barr virus seronegative and seropositive adult blood donors. Scand J Immunol. 1998;48(3):219–22.CrossRefPubMed
22.
go back to reference Somers W, Stahl M, Seehra JS. 1.9 A crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling. EMBO J. 1997;16(5):989–97.PubMedCentralCrossRefPubMed Somers W, Stahl M, Seehra JS. 1.9 A crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling. EMBO J. 1997;16(5):989–97.PubMedCentralCrossRefPubMed
23.
24.
go back to reference Lim WY, Chen Y, Ali SM, Chuah KL, Eng P, Leong SS, et al. Polymorphisms in inflammatory pathway genes, host factors and lung cancer risk in Chinese female never-smokers. Carcinogenesis. 2011;32(4):522–9.CrossRefPubMed Lim WY, Chen Y, Ali SM, Chuah KL, Eng P, Leong SS, et al. Polymorphisms in inflammatory pathway genes, host factors and lung cancer risk in Chinese female never-smokers. Carcinogenesis. 2011;32(4):522–9.CrossRefPubMed
25.
go back to reference Bao S, Yang W, Zhou S, Ye Z. Relationship between single nucleotide polymorphisms in –174G/C and –634C/G promoter region of interleukin-6 and prostate cancer. J Huazhong Univ Sci Technolog Med Sci. 2008;28(6):693–6.CrossRefPubMed Bao S, Yang W, Zhou S, Ye Z. Relationship between single nucleotide polymorphisms in –174G/C and –634C/G promoter region of interleukin-6 and prostate cancer. J Huazhong Univ Sci Technolog Med Sci. 2008;28(6):693–6.CrossRefPubMed
26.
go back to reference Bai L, Yu H, Wang H, Su H, Zhao J, Zhao Y. Genetic single-nucleotide polymorphisms of inflammation-related factors associated with risk of lung cancer. Med Oncol. 2013;30(1):414.CrossRefPubMed Bai L, Yu H, Wang H, Su H, Zhao J, Zhao Y. Genetic single-nucleotide polymorphisms of inflammation-related factors associated with risk of lung cancer. Med Oncol. 2013;30(1):414.CrossRefPubMed
27.
go back to reference Pan M, Gao SP, Jiang MH, Guo J, Zheng JG, Zhu JH. Interleukin 6 promoter polymorphisms in normal Han Chinese population: frequencies and effects on inflammatory markers. J Investig Med. 2011;59(2):272–6.PubMed Pan M, Gao SP, Jiang MH, Guo J, Zheng JG, Zhu JH. Interleukin 6 promoter polymorphisms in normal Han Chinese population: frequencies and effects on inflammatory markers. J Investig Med. 2011;59(2):272–6.PubMed
28.
go back to reference Jang Y, Kim OY, Hyun YJ, Chae JS, Koh SJ, Heo YM, et al. Interleukin-6-572C > G polymorphism-association with inflammatory variables in Korean men with coronary artery disease. Transl Res. 2008;151(3):154–61.CrossRefPubMed Jang Y, Kim OY, Hyun YJ, Chae JS, Koh SJ, Heo YM, et al. Interleukin-6-572C > G polymorphism-association with inflammatory variables in Korean men with coronary artery disease. Transl Res. 2008;151(3):154–61.CrossRefPubMed
29.
go back to reference Kitamura A, Hasegawa G, Obayashi H, Kamiuchi K, Ishii M, Yano M, et al. Interleukin-6 polymorphism (–634C/G) in the promotor region and the progression of diabetic nephropathy in type 2 diabetes. Diabet Med. 2002;19(12):1000–5.CrossRefPubMed Kitamura A, Hasegawa G, Obayashi H, Kamiuchi K, Ishii M, Yano M, et al. Interleukin-6 polymorphism (–634C/G) in the promotor region and the progression of diabetic nephropathy in type 2 diabetes. Diabet Med. 2002;19(12):1000–5.CrossRefPubMed
30.
go back to reference Shibata N, Ohnuma T, Takahashi T, Baba H, Ishizuka T, Ohtsuka M, et al. Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype–phenotype association study in Japanese cases. Am J Med Genet. 2002;114(4):436–9.CrossRefPubMed Shibata N, Ohnuma T, Takahashi T, Baba H, Ishizuka T, Ohtsuka M, et al. Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype–phenotype association study in Japanese cases. Am J Med Genet. 2002;114(4):436–9.CrossRefPubMed
31.
go back to reference Balasubramanian SP, Azmy IA, Higham SE, Wilson AG, Cross SS, Cox A, et al. Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review. BMC Cancer. 2006;6:188.PubMedCentralCrossRefPubMed Balasubramanian SP, Azmy IA, Higham SE, Wilson AG, Cross SS, Cox A, et al. Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review. BMC Cancer. 2006;6:188.PubMedCentralCrossRefPubMed
32.
go back to reference Oh K, Ko E, Kim HS, Park AK, Moon HG, Noh DY, et al. Transglutaminase 2 facilitates the distant hematogenous metastasis of breast cancer by modulating interleukin-6 in cancer cells. Breast Cancer Res. 2011;13(5):R96.PubMedCentralCrossRefPubMed Oh K, Ko E, Kim HS, Park AK, Moon HG, Noh DY, et al. Transglutaminase 2 facilitates the distant hematogenous metastasis of breast cancer by modulating interleukin-6 in cancer cells. Breast Cancer Res. 2011;13(5):R96.PubMedCentralCrossRefPubMed
33.
go back to reference Yadav A, Kumar B, Datta J, Teknos TN, Kumar P. IL-6 promotes head and neck tumor metastasis by inducing epithelial–mesenchymal transition via the JAK–STAT3–SNAIL signaling pathway. Mol Cancer Res. 2011;9(12):1658–67.PubMedCentralCrossRefPubMed Yadav A, Kumar B, Datta J, Teknos TN, Kumar P. IL-6 promotes head and neck tumor metastasis by inducing epithelial–mesenchymal transition via the JAK–STAT3–SNAIL signaling pathway. Mol Cancer Res. 2011;9(12):1658–67.PubMedCentralCrossRefPubMed
34.
go back to reference Riedel F, Zaiss I, Herzog D, Gotte K, Naim R, Hormann K. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma. Anticancer Res. 2005;25(4):2761–5.PubMed Riedel F, Zaiss I, Herzog D, Gotte K, Naim R, Hormann K. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma. Anticancer Res. 2005;25(4):2761–5.PubMed
35.
go back to reference Zhang D, Zhou Y, Wu L, Wang S, Zheng H, Yu B, et al. Association of IL-6 gene polymorphisms with cachexia susceptibility and survival time of patients with pancreatic cancer. Ann Clin Lab Sci. 2008;38(2):113–9.PubMed Zhang D, Zhou Y, Wu L, Wang S, Zheng H, Yu B, et al. Association of IL-6 gene polymorphisms with cachexia susceptibility and survival time of patients with pancreatic cancer. Ann Clin Lab Sci. 2008;38(2):113–9.PubMed
36.
go back to reference Brull DJ, Montgomery HE, Sanders J, Dhamrait S, Luong L, Rumley A, et al. Interleukin-6 gene –174 g > c and –572 g > c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol. 2001;21(9):1458–63.CrossRefPubMed Brull DJ, Montgomery HE, Sanders J, Dhamrait S, Luong L, Rumley A, et al. Interleukin-6 gene –174 g > c and –572 g > c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol. 2001;21(9):1458–63.CrossRefPubMed
37.
go back to reference Malarstig A, Wallentin L, Siegbahn A. Genetic variation in the interleukin-6 gene in relation to risk and outcomes in acute coronary syndrome. Thromb Res. 2007;119(4):467–73.CrossRefPubMed Malarstig A, Wallentin L, Siegbahn A. Genetic variation in the interleukin-6 gene in relation to risk and outcomes in acute coronary syndrome. Thromb Res. 2007;119(4):467–73.CrossRefPubMed
38.
go back to reference Basso F, Lowe GD, Rumley A, McMahon AD, Humphries SE. Interleukin-6–174G > C polymorphism and risk of coronary heart disease in West of Scotland coronary prevention study (WOSCOPS). Arterioscler Thromb Vasc Biol. 2002;22(4):599–604.CrossRefPubMed Basso F, Lowe GD, Rumley A, McMahon AD, Humphries SE. Interleukin-6–174G > C polymorphism and risk of coronary heart disease in West of Scotland coronary prevention study (WOSCOPS). Arterioscler Thromb Vasc Biol. 2002;22(4):599–604.CrossRefPubMed
39.
go back to reference Tan EL, Selvaratnam G, Kananathan R, Sam CK. Quantification of Epstein–Barr virus DNA load, interleukin-6, interleukin-10, transforming growth factor-beta1 and stem cell factor in plasma of patients with nasopharyngeal carcinoma. BMC Cancer. 2006;6:227.PubMedCentralCrossRefPubMed Tan EL, Selvaratnam G, Kananathan R, Sam CK. Quantification of Epstein–Barr virus DNA load, interleukin-6, interleukin-10, transforming growth factor-beta1 and stem cell factor in plasma of patients with nasopharyngeal carcinoma. BMC Cancer. 2006;6:227.PubMedCentralCrossRefPubMed
40.
go back to reference Duffy SA, Taylor JM, Terrell JE, Islam M, Li Y, Fowler KE, et al. Interleukin-6 predicts recurrence and survival among head and neck cancer patients. Cancer. 2008;113(4):750–7.CrossRefPubMed Duffy SA, Taylor JM, Terrell JE, Islam M, Li Y, Fowler KE, et al. Interleukin-6 predicts recurrence and survival among head and neck cancer patients. Cancer. 2008;113(4):750–7.CrossRefPubMed
41.
go back to reference Bennermo M, Held C, Green F, Strandberg LE, Ericsson CG, Hansson LO, et al. Prognostic value of plasma interleukin-6 concentrations and the –174 G > C and –572 G > C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis. Atherosclerosis. 2004;174(1):157–63.CrossRefPubMed Bennermo M, Held C, Green F, Strandberg LE, Ericsson CG, Hansson LO, et al. Prognostic value of plasma interleukin-6 concentrations and the –174 G > C and –572 G > C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis. Atherosclerosis. 2004;174(1):157–63.CrossRefPubMed
42.
go back to reference Jin G, Deng Y, Miao R, Hu Z, Zhou Y, Tan Y, et al. TGFB1 and TGFBR2 functional polymorphisms and risk of esophageal squamous cell carcinoma: a case-control analysis in a Chinese population. J Cancer Res Clin Oncol. 2008;134(3):345–51.CrossRefPubMed Jin G, Deng Y, Miao R, Hu Z, Zhou Y, Tan Y, et al. TGFB1 and TGFBR2 functional polymorphisms and risk of esophageal squamous cell carcinoma: a case-control analysis in a Chinese population. J Cancer Res Clin Oncol. 2008;134(3):345–51.CrossRefPubMed
43.
go back to reference Park KH, Lo Han SG, Whang YM, Lee HJ, Yoo YD, Lee JW, et al. Single nucleotide polymorphisms of the TGFB1 gene and lung cancer risk in a Korean population. Cancer Genet Cytogenet. 2006;169(1):39–44.CrossRefPubMed Park KH, Lo Han SG, Whang YM, Lee HJ, Yoo YD, Lee JW, et al. Single nucleotide polymorphisms of the TGFB1 gene and lung cancer risk in a Korean population. Cancer Genet Cytogenet. 2006;169(1):39–44.CrossRefPubMed
44.
go back to reference Zhang P, Di JZ, Zhu ZZ, Wu HM, Wang Y, Zhu G, et al. Association of transforming growth factor-beta 1 polymorphisms with genetic susceptibility to TNM stage I or II gastric cancer. Jpn J Clin Oncol. 2008;38(12):861–6.CrossRefPubMed Zhang P, Di JZ, Zhu ZZ, Wu HM, Wang Y, Zhu G, et al. Association of transforming growth factor-beta 1 polymorphisms with genetic susceptibility to TNM stage I or II gastric cancer. Jpn J Clin Oncol. 2008;38(12):861–6.CrossRefPubMed
45.
go back to reference Crivello A, Giacalone A, Vaglica M, Scola L, Forte GI, Macaluso MC, et al. Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma. Ann N Y Acad Sci. 2006;1089:98–103.CrossRefPubMed Crivello A, Giacalone A, Vaglica M, Scola L, Forte GI, Macaluso MC, et al. Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma. Ann N Y Acad Sci. 2006;1089:98–103.CrossRefPubMed
46.
go back to reference Breast Cancer Association Consortium. Commonly studied single-nucleotide polymorphisms and breast cancer. J Natl Cancer Inst. 2006;98(19):1382–96.CrossRef Breast Cancer Association Consortium. Commonly studied single-nucleotide polymorphisms and breast cancer. J Natl Cancer Inst. 2006;98(19):1382–96.CrossRef
47.
go back to reference Wei YS, Zhu YH, Du B, Yang ZH, Liang WB, Lv ML, et al. Association of transforming growth factor-beta1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma. Clin Chim Acta. 2007;380(1–2):165–9.CrossRefPubMed Wei YS, Zhu YH, Du B, Yang ZH, Liang WB, Lv ML, et al. Association of transforming growth factor-beta1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma. Clin Chim Acta. 2007;380(1–2):165–9.CrossRefPubMed
48.
go back to reference Zienolddiny S, Ryberg D, Maggini V, Skaug V, Canzian F, Haugen A. Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancer. Int J Cancer. 2004;109(3):353–6.CrossRefPubMed Zienolddiny S, Ryberg D, Maggini V, Skaug V, Canzian F, Haugen A. Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancer. Int J Cancer. 2004;109(3):353–6.CrossRefPubMed
49.
go back to reference Liao WC, Lin JT, Wu CY, Huang SP, Lin MT, Wu AS, et al. Serum interleukin-6 level but not genotype predicts survival after resection in stages II and III gastric carcinoma. Clin Cancer Res. 2008;14(2):428–34.CrossRefPubMed Liao WC, Lin JT, Wu CY, Huang SP, Lin MT, Wu AS, et al. Serum interleukin-6 level but not genotype predicts survival after resection in stages II and III gastric carcinoma. Clin Cancer Res. 2008;14(2):428–34.CrossRefPubMed
Metadata
Title
RETRACTED ARTICLE: Relationships between genetic polymorphisms in inflammation-related factor gene and the pathogenesis of nasopharyngeal cancer
Authors
Yan-Li Qu
Hong Yu
Yan-Zhi Chen
Yu-Xia Zhao
Guang-Jun Chen
Lu Bai
Dan Liu
Hong-Xin Su
He-Tong Wang
Publication date
01-09-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 9/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-2123-6

Other articles of this Issue 9/2014

Tumor Biology 9/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine